Report
EUR 14.37 For Business Accounts Only

An unfavourable environment weighs on PARKWAY LIFE REIT, which sees a downgrade to Neutral

The independent financial analyst theScreener just requalified the general evaluation of PARKWAY LIFE REIT (SG), active in the Real Estate Investment Trusts industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date February 1, 2022, the closing price was SGD 4.79 and its target price was estimated at SGD 4.55.
Underlying
Parkway Life Real Estate Investment Trust

Parkway Life Real Estate Investment Trust is a healthcare real estate investment trust. Co. invests in income-producing real estate and/or real estate-related assets in the Asia-Pacific region (including Singapore) that are used primarily for healthcare and/or healthcare-related purposes. This include, but not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices. Co.'s segments include Hospital Properties; Nursing Homes; and Pharmaceutical Manufacturing and Distribution Facility.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch